An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|6|659-669

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.6, 2011-09, pp. : 659-669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3188-3210

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A2B receptors: a novel therapeutic target in asthma?

By Feoktistov I.   Biaggioni I.   Polosa R.   Holgate S.T.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 4, 1998-04 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 686-700

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapy in Parkinson's disease: adenosine A2A receptor antagonists

By Szabóó Nikoletta   Kincses Zsigmond Tamáás   Véécsei Láászlóó  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 441-455

Informa Healthcare

Access to resources Recommend Favorite

Adenosine A 2A receptor antagonists as new agents for the treatment of Parkinson's disease

By Richardson P.J.   Kase H.   Jenner P.G.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 9, 1997-10 ,pp. : 338-344

Elsevier

Access to resources Recommend Favorite